Fayuvi is Ultragenyx's second approved gene therapy after Genglycos (pariglasgene brecaparvovec) for glycogen storage disease ...

Jiangsu Hengrui Pharma's oral thrombopoietin (TPO) receptor agonist hetrombopag has been approved in China to treat low ...

Generating good-quality patient experience data (PED) is becoming increasingly important for medicine development, and ...

Chinese tech giant ByteDance – best known as the parent of social media app TikTok – has completed a $290 million financing ...

Around 1,000 patients in England with a form of incurable breast cancer will be able to get access to AstraZeneca and Daiichi ...

Boardrooms, Advisory Boards, and governance teams saw plenty of activity in August, with companies across biotech, ...

Frehemgo (denecimig, also known as Mim8) – which picked up its first world approval in Saudi Arabia a few days ago – has been ...

Avalere Health was the most successful agency, winning three Golds, a Silver and the highly contested accolade of PMi Agency ...

At present, the only FDA-approved oral therapies for HAE are BioCryst's Orladeyo (berotralstat) and KalVista Pharma's Ekterly ...

Curium's radioligand therapy Bexlutry has been approved in the US as a generic – or 'radioligand equivalent' (RLE) – of ...

Amgen's fast-growing cancer immunotherapy Imdelltra could move into the first-line setting in small cell lung cancer (SCLC), ...

Speaking to investors and analysts at its capital markets day in London, UK, Sandoz presented its new strategy – Bio100 – ...